Lifeward (NASDAQ:LFWD) Shares Down 2.1% – What’s Next?

Lifeward Ltd. (NASDAQ:LFWD) fell 2.1% during trading on Thursday . The company traded as low as $0.5150 and last traded at $0.52. 139,117 shares changed hands during trading, a decline of 37% from the average session volume of 219,376 shares. The stock had previously closed at $0.5311.

Analyst Ratings Changes

LFWD has been the topic of a number of research analyst reports. HC Wainwright decreased their price target on shares of Lifeward from $13.00 to $4.50 and set a “buy” rating on the stock in a report on Tuesday, November 18th. Weiss Ratings restated a “sell (e+)” rating on shares of Lifeward in a report on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $4.25.

Lifeward Trading Down 18.3%

The stock has a 50-day simple moving average of $0.61 and a 200-day simple moving average of $0.63. The company has a market capitalization of $7.78 million, a price-to-earnings ratio of -0.14 and a beta of 0.16.

Lifeward’s stock is set to reverse split on the morning of Tuesday, February 24th. The 1-12 reverse split was announced on Friday, February 20th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, February 23rd.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Jane Street Group LLC grew its position in shares of Lifeward by 77.3% during the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after acquiring an additional 29,927 shares during the last quarter. HRT Financial LP increased its stake in shares of Lifeward by 149.7% in the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after purchasing an additional 29,423 shares during the period. Finally, Citadel Advisors LLC increased its stake in shares of Lifeward by 1,271.8% in the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after purchasing an additional 198,406 shares during the period. Institutional investors and hedge funds own 26.76% of the company’s stock.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.